{{ variable.name }}
Halogenated Aniline Key Intermediate for Anticancer API Synthesis
4-Bromo-2,6-difluoroaniline (CAS 1868-81-7) is a specialized halogenated aniline derivative used as a key pharmaceutical intermediate in the synthesis of Abemaciclib, an anticancer drug for targeted therapy. With a purity of ≥98.0% (HPLC/GC) and a well-defined crystalline form, this intermediate ensures reliable performance in downstream coupling and amination reactions.
| Parameter | Value |
|---|---|
| CAS Number | 1868-81-7 |
| Molecular Formula | C₆H₄BrF₂N |
| Molecular Weight | 207.91 |
| Appearance | White to off-white crystalline solid |
| Purity | ≥98.0% (HPLC/GC) |
| Density | 1.768±0.06 g/cm³ |
| Boiling Point | 239.4±35.0 °C |
| Melting Point | 57–61 °C |
| Storage Conditions | Sealed, dry, keep away from light at 2–8 °C |
Available in research quantities (grams) and commercial batches (up to hundreds of kilograms) per customer requirements. Custom packaging and COA documentation provided.
Halogenated aniline aromatic compound with fluorine and bromine substitutions on the benzene ring. This structural motif is essential for the C–N and C–C bond formations in Abemaciclib synthesis.
Pharmaceutical manufacturing industry, particularly in anti-cancer drug synthesis and targeted therapy development. Used in the production of Abemaciclib API and related innovative drug R&D.
We supply ≥98.0% purity (HPLC/GC) as standard.
Sealed, dry, away from light at 2–8°C to maintain stability.
Yes, packaging can be customized based on order quantity.
Yes, it is used in commercial production of Abemaciclib intermediates.
Yes, each batch is supplied with a COA.
For inquiries, contact: Xu Tianxia, Email: Xutx@haohong-pharma.com, Tel: +86 180-6854-1569.

